Depomed has attained Zipsor (diclofenac potassium) Liquid Filled Capsule rights from Xanodyne Pharmaceuticals for $25.9m of cash. Depomed acquired the product in return for potential milestone payments based on the sales of Zipsor and ...
Tags: Zipsor Liquid Filled Capsule, Pharmaceuticals, moderate acute pain